Assay Detail
Functional
CHEMBL3267339
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Agonist activity at human recombinant adenosine receptor A2b by cAMP assay
13
Total Activities
13
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Adenosine A2A receptor as a drug discovery target.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 13 | 5.37 | 6.48 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL464859 | NECA | — | 1 | 6.48 |
| CHEMBL186113 | GW-328267 | 1.0 | 1 | 5.89 |
| CHEMBL3350613 | — | — | 1 | 5.21 |
| CHEMBL317052 | REGADENOSON ANHYDROUS | 4.0 | 1 | 5.00 |
| CHEMBL1950553 | SONEDENOSON | 2.0 | 1 | 5.00 |
| CHEMBL477 | ADENOSINE | 4.0 | 1 | 4.62 |
| CHEMBL285819 | — | — | 1 | - |
| CHEMBL1256672 | — | — | 1 | - |
| CHEMBL331372 | CGS-21680 | — | 1 | - |
| CHEMBL1950554 | BINODENOSON | 3.0 | 1 | - |
| CHEMBL1950649 | APADENOSON | 3.0 | 1 | - |
| CHEMBL3260724 | — | — | 1 | - |
| CHEMBL487497 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL464859 | NECA | EC50 | = | 330.0 | nM | 6.48 |
| CHEMBL186113 | GW-328267 | EC50 | = | 1300.0 | nM | 5.89 |
| CHEMBL3350613 | — | EC50 | = | 6100.0 | nM | 5.21 |
| CHEMBL317052 | REGADENOSON ANHYDROUS | EC50 | = | 10000.0 | nM | 5.00 |
| CHEMBL1950553 | SONEDENOSON | EC50 | = | 10000.0 | nM | 5.00 |
| CHEMBL477 | ADENOSINE | EC50 | = | 24000.0 | nM | 4.62 |
| CHEMBL285819 | — | EC50 | - | — | - | |
| CHEMBL1256672 | — | EC50 | - | — | - | |
| CHEMBL331372 | CGS-21680 | EC50 | = | 361000.0 | nM | - |
| CHEMBL1950554 | BINODENOSON | EC50 | > | 100000.0 | nM | - |
| CHEMBL1950649 | APADENOSON | EC50 | - | — | - | |
| CHEMBL3260724 | — | EC50 | - | — | - | |
| CHEMBL487497 | — | EC50 | - | — | - |